Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance

Clinicians have very limited options to treat triple-negative breast cancer (TNBC) due to the lack of effective targeted drugs. Recently, the findings of the mechanism underlying tumor-intrinsic immune escape have fueled a wave of studies into immunotherapy in breast cancer (BC). Compared with other...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Xupeng Bai, Jie Ni, Julia Beretov, Peter Graham, Yong Li
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/b70b5e3637074d7693e3d1e8c38ef8fc
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!